Open access

P04.03 Immuno-analytics of patients with gastric cancer: impact of systemic polychemotherapy on peripheral T-cell fitness and immunologic features of gastric cancer tissue
T Haase, A Grosser, L Rohrbacher, L Weiss, K Dorman, D Zhang, C Gießen-Jung, S Boeck, V Heinemann, M Subklewe, A Reischer

Journal for ImmunoTherapy of Cancer Mar 2024, 12 (Suppl 1) A21; DOI: 10.1136/jitc-2024-ITOC10.38
P04.04 Single cell transcriptomics reveals cancer associated fibroblasts enable modeling of tumor associated macrophage like phenotypes and treatment responses in primary colorectal cancer organoid cultures
J Kabiljo, A Theophil, J Homola, A Renner, J Karall, N Hartman, S Stang, L Tran, J Laengle, A Kulu, A Chen, M Fabits, V Atanasova, H Walczak, D Herndler-Brandstetter, G Egger, H Dolznig, A Kusienicka, M Farlik, M Bergmann

Journal for ImmunoTherapy of Cancer Mar 2024, 12 (Suppl 1) A21-A22; DOI: 10.1136/jitc-2024-ITOC10.39
P05.01 Sensitizing immunotherapy refractory prostate cancer with optimized ketogenic diet regimen and epigenetic reprogramming
X Lu, S Murphy, S Rahmy, D Gan, J Li, X Lu

Journal for ImmunoTherapy of Cancer Mar 2024, 12 (Suppl 1) A22; DOI: 10.1136/jitc-2024-ITOC10.40
P05.02 Investigating the kinetics of CD3 binding and trafficking in real-time
P Zucchetti, S Bondza, S Lundsten Salomonsson

Journal for ImmunoTherapy of Cancer Mar 2024, 12 (Suppl 1) A22-A23; DOI: 10.1136/jitc-2024-ITOC10.41
P06.01 Gain-of-function CARD11 signalling in B cells causes pathological lymphoproliferative disease in mice which is strictly dependent on MALT1 activity
A Kratzert, E Morrish, SJ Keppler, J Ruland

Journal for ImmunoTherapy of Cancer Mar 2024, 12 (Suppl 1) A23; DOI: 10.1136/jitc-2024-ITOC10.42
P09.01 Adapting immune cells to the hypoglycemic tumor microenvironment by solute carrier 2a1 (Slc2a1/GLUT1) overexpression
ME Kirmaier, BL Cadilha, A Hadzic, W Schmitz, MR Benmebarek, D Briukhovetska, S Michaelides, V Buschinger, B Tast, CH Bönigk, S Oganesian, L Vona, A Tischmacher, V Heissmeyer, M Vaeth, VR Buchholz, M Eilers, M von Bergwelt-Baildon, M Subklewe, S Kobold, S Theurich

Journal for ImmunoTherapy of Cancer Mar 2024, 12 (Suppl 1) A25; DOI: 10.1136/jitc-2024-ITOC10.45
P09.04 Isolation of a high avidity TCR targeting a newly identified epitope of a common cancer testis antigen expressed by solid tumors
E Sivro, M Klatt, S Elezkurtaj, C Freund, C Grunert, U Keller, A Busse

Journal for ImmunoTherapy of Cancer Mar 2024, 12 (Suppl 1) A26-A27; DOI: 10.1136/jitc-2024-ITOC10.48
P09.06 Establishing a mouse model to visualize limitations of CAR-T cells activity in solid tumors
B Arnaud, M Ruggiu, Z Garcia, F Lemaître, C Grandjean, P Bousso

Journal for ImmunoTherapy of Cancer Mar 2024, 12 (Suppl 1) A27-A28; DOI: 10.1136/jitc-2024-ITOC10.50
P09.05 Novel A20 based therapeutic strategies to fight lung cancer
M Homolya, M Machtinger, S Lim, Z Krevh, E Casanova, HP Moll

Journal for ImmunoTherapy of Cancer Mar 2024, 12 (Suppl 1) A27; DOI: 10.1136/jitc-2024-ITOC10.49
P10.01 Nutritional and immunometabolic measures for risk assessment in allogeneic hematopoietic stem cell transplantation
H Thurisch, K Althoff, S Leitzke, U Holtick, C Scheid, S Oganesian, M Funk, D Cordas dos Santos, M von Bergwelt-Baildon, S Theurich

Journal for ImmunoTherapy of Cancer Mar 2024, 12 (Suppl 1) A28-A29; DOI: 10.1136/jitc-2024-ITOC10.52

Main menu

Open access

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Open access

Pages